Malignancy and the Risks of Biologic Therapies
Author:
Publisher
Elsevier BV
Subject
Rheumatology
Reference74 articles.
1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015
2. Observational studies on the risk of cancer associated with tumor necrosis factor inhibitors in rheumatoid arthritis: a review of their methodologies and results;Solomon;Arthritis Rheum,2012
3. Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis;Simon;Arthritis Res Ther,2015
4. The risk of lymphoma development in autoimmune diseases: a meta-analysis;Zintzaras;Arch Intern Med,2005
5. Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a south European population;Abasolo;Semin Arthritis Rheum,2008
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An Osteoimmunomodulatory Biopatch Potentiates Stem Cell Therapies for Bone Regeneration by Simultaneously Regulating IL‐17/Ferroptosis Signaling Pathways;Advanced Science;2024-07-18
2. Causal inference between rheumatoid arthritis and prostate cancer;Clinical and Experimental Medicine;2023-08-11
3. DMARD (disease-modifying antirheumatic drug) treatment in patients with former or current cancer;Zeitschrift für Rheumatologie;2023-02-09
4. Stem Cell‐Niche Engineering via Multifunctional Hydrogel Potentiates Stem Cell Therapies for Inflammatory Bone Loss;Advanced Functional Materials;2022-11-04
5. Immune-checkpoint inhibitor use in patients with cancer and pre-existing autoimmune diseases;Nature Reviews Rheumatology;2022-10-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3